Headache clinical trials at UC Davis
3 in progress, 1 open to eligible people
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
open to eligible people ages 18-100
The study titled "Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
Sacramento, California
Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sorry, not currently recruiting here
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to < 18 years of age).
Sacramento, California and other locations
Children and Adolescents With Migraine: Acute Treatment
Sorry, not currently recruiting here
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
Sacramento, California and other locations
Last updated: